Related Experiment Video
Updated: Aug 18, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Addressing the diagnostic gap in hypertension through possible interventions and scale-up: A microsimulation study
Lisa Koeppel1, Sabine Dittrich2,3, Sergio Brenner Miguel4
1Division of Infectious Diseases and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Improving hypertension screening coverage and completion in low- and middle-income countries can prevent millions of cardiovascular deaths. Focusing on screening completion is more impactful than solely improving diagnostic accuracy for hypertension.
Area of Science:
- Public Health
- Epidemiology
- Health Economics
Background:
- Cardiovascular diseases (CVDs) are the leading global cause of mortality, with 80% of deaths occurring in low- and middle-income countries (LMICs).
- Hypertension (HTN) is the primary modifiable risk factor for CVD, yet its diagnosis and management remain suboptimal in LMICs.
- The comparative effectiveness of interventions to improve HTN screening accuracy, reach, and completion has not been fully estimated.
Purpose of the Study:
- To estimate the impact of different hypertension screening strategies on HTN-induced morbidity and mortality in LMICs.
- To compare the effectiveness of improved diagnostic accuracy, increased screening coverage, and enhanced screening completion using digital tools.
- To provide evidence for optimizing public health interventions for hypertension management in resource-limited settings.
Main Methods:
- A microsimulation study using nationally representative individual-level data and global burden of disease data.
- Modeling four scenarios: lower diagnostic accuracy (S1), improved diagnostic accuracy (S2), increased screening reach (S3), and enhanced screening completion with digital tools (S4), compared to standard care (S0).
- Investigating the impact on morbidity and mortality over a 10-year period for a population with 31% HTN prevalence, 60% undiagnosed.
Main Results:
- Improving diagnostic accuracy alone could prevent 0.6% of HTN-induced deaths over 10 years.
- Increasing screening coverage and completion could prevent approximately 40 million (12.7%) HTN-induced deaths within the same timeframe.
- Doubling screening coverage alone could prevent over 3.3 million (12.1%) CVD events in 10 years.
Conclusions:
- While improving diagnostic accuracy is beneficial, enhancing screening coverage and completion is significantly more impactful for reducing HTN-related deaths in LMICs.
- Emphasis should be placed on implementation strategies that increase the reach and completion rates of blood pressure screening.
- Wider adoption of user-friendly tools, like automated digital blood pressure devices, can facilitate better screening completion.
Related Concept Videos
Hypertension V: Nursing Management
Errors occurring during blood pressure monitoring
Several factors...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension I: Introduction
Hypertension II: Pathophysiology

